Merck KGaA (Germany)
GE Healthcare (U.S.)
Sigma-Aldrich Corporation (Germany)
Eppendorf AG (Germany)
Thermo Fisher Scientific, Inc. (U.S.)
Pall Corporation (U.S.)
FiberCell Systems Inc. (U.S.)
Sartorius AG (Germany)
Cellab GmbH (Germany)
INTEGRA Biosciences AG (Switzerland)
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Antibody Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Antibody Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Antibody Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Antibody Market-Segmentation by Type
5.1 Monoclonal Antibodies
5.2 Polyclonal Antibodies
5.3 Antibody-drug Complexes (ADCs)
6 Global Antibody Market-Segmentation by Application
6.1 Therapeutic
6.2 Research
6.3 Diagnostic
7 Global Antibody Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Merck KGaA (Germany)
8.1.1 Merck KGaA (Germany) Profile
8.1.2 Merck KGaA (Germany) Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Merck KGaA (Germany) Product/Solution Launches and Enhancements Analysis
8.1.4 Merck KGaA (Germany) Business Overview/Recent Development/Acquisitions
8.2 GE Healthcare (U.S.)
8.2.1 GE Healthcare (U.S.) Profile
8.2.2 GE Healthcare (U.S.) Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 GE Healthcare (U.S.) Product/Solution Launches and Enhancements Analysis
8.2.4 GE Healthcare (U.S.) Business Overview/Recent Development/Acquisitions
8.3 Sigma-Aldrich Corporation (Germany)
8.3.1 Sigma-Aldrich Corporation (Germany) Profile
8.3.2 Sigma-Aldrich Corporation (Germany) Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Sigma-Aldrich Corporation (Germany) Product/Solution Launches and Enhancements Analysis
8.3.4 Sigma-Aldrich Corporation (Germany) Business Overview/Recent Development/Acquisitions
8.4 Eppendorf AG (Germany)
8.4.1 Eppendorf AG (Germany) Profile
8.4.2 Eppendorf AG (Germany) Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Eppendorf AG (Germany) Product/Solution Launches and Enhancements Analysis
8.4.4 Eppendorf AG (Germany) Business Overview/Recent Development/Acquisitions
8.5 Thermo Fisher Scientific, Inc. (U.S.)
8.5.1 Thermo Fisher Scientific, Inc. (U.S.) Profile
8.5.2 Thermo Fisher Scientific, Inc. (U.S.) Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Thermo Fisher Scientific, Inc. (U.S.) Product/Solution Launches and Enhancements Analysis
8.5.4 Thermo Fisher Scientific, Inc. (U.S.) Business Overview/Recent Development/Acquisitions
8.6 Pall Corporation (U.S.)
8.6.1 Pall Corporation (U.S.) Profile
8.6.2 Pall Corporation (U.S.) Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Pall Corporation (U.S.) Product/Solution Launches and Enhancements Analysis
8.6.4 Pall Corporation (U.S.) Business Overview/Recent Development/Acquisitions
8.7 FiberCell Systems Inc. (U.S.)
8.7.1 FiberCell Systems Inc. (U.S.) Profile
8.7.2 FiberCell Systems Inc. (U.S.) Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 FiberCell Systems Inc. (U.S.) Product/Solution Launches and Enhancements Analysis
8.7.4 FiberCell Systems Inc. (U.S.) Business Overview/Recent Development/Acquisitions
8.8 Sartorius AG (Germany)
8.8.1 Sartorius AG (Germany) Profile
8.8.2 Sartorius AG (Germany) Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Sartorius AG (Germany) Product/Solution Launches and Enhancements Analysis
8.8.4 Sartorius AG (Germany) Business Overview/Recent Development/Acquisitions
8.9 Cellab GmbH (Germany)
8.9.1 Cellab GmbH (Germany) Profile
8.9.2 Cellab GmbH (Germany) Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Cellab GmbH (Germany) Product/Solution Launches and Enhancements Analysis
8.9.4 Cellab GmbH (Germany) Business Overview/Recent Development/Acquisitions
8.10 INTEGRA Biosciences AG (Switzerland)
8.10.1 INTEGRA Biosciences AG (Switzerland) Profile
8.10.2 INTEGRA Biosciences AG (Switzerland) Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 INTEGRA Biosciences AG (Switzerland) Product/Solution Launches and Enhancements Analysis
8.10.4 INTEGRA Biosciences AG (Switzerland) Business Overview/Recent Development/Acquisitions
9 Global Antibody Market-Segmentation by Geography
10 North America
10.1 North America Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Antibody Production Analysis from 2015-2020
10.4 North America Antibody Consumption Analysis from 2015-2020
10.5 North America Antibody Import and Export from 2015-2020
10.6 North America Antibody Value, Production and Market Share by Type (2015-2020)
10.7 North America Antibody Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Antibody by Country (United States, Canada)
10.8.1 North America Antibody Sales by Country (2015-2020)
10.8.2 North America Antibody Consumption Value by Country (2015-2020)
10.9 North America Antibody Market PEST Analysis
11 Europe
11.1 Europe Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Antibody Production Analysis from 2015-2020
11.4 Europe Antibody Consumption Analysis from 2015-2020
11.5 Europe Antibody Import and Export from 2015-2020
11.6 Europe Antibody Value, Production and Market Share by Type (2015-2020)
11.7 Europe Antibody Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Antibody by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Antibody Sales by Country (2015-2020)
11.8.2 Europe Antibody Consumption Value by Country (2015-2020)
11.9 Europe Antibody Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Antibody Production Analysis from 2015-2020
12.4 Asia-Pacific Antibody Consumption Analysis from 2015-2020
12.5 Asia-Pacific Antibody Import and Export from 2015-2020
12.6 Asia-Pacific Antibody Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Antibody Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Antibody by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Antibody Sales by Country (2015-2020)
12.8.2 Asia-Pacific Antibody Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Antibody Market PEST Analysis
13 Latin America
13.1 Latin America Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Antibody Production Analysis from 2015-2020
13.4 Latin America Antibody Consumption Analysis from 2015-2020
13.5 Latin America Antibody Import and Export from 2015-2020
13.6 Latin America Antibody Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Antibody Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Antibody by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Antibody Sales by Country (2015-2020)
13.8.2 Latin America Antibody Consumption Value by Country (2015-2020)
13.9 Latin America Antibody Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Antibody Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Antibody Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Antibody Production Analysis from 2015-2020
14.4 Middle East & Africa Antibody Consumption Analysis from 2015-2020
14.5 Middle East & Africa Antibody Import and Export from 2015-2020
14.6 Middle East & Africa Antibody Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Antibody Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Antibody by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Antibody Sales by Country (2015-2020)
14.8.2 Middle East & Africa Antibody Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Antibody Market PEST Analysis
15 Future Forecast of the Global Antibody Market from 2020-2028
15.1 Future Forecast of the Global Antibody Market from 2020-2028 Segment by Region
15.2 Global Antibody Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Antibody Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
